KIDNEY TRANSPLANT RECIPIENTS
Clinical trials for KIDNEY TRANSPLANT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT RECIPIENTS trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Transplant patients get stronger COVID protection by temporarily lowering immune drugs
Disease control CompletedThis study looked at 48 kidney and liver transplant recipients who had a weak antibody response after their initial COVID-19 vaccines. Researchers gave them an extra mRNA booster shot, and in some patients they temporarily reduced immune-suppressing medications to see if that wou…
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 17, 2026 11:45 UTC
-
Could a Once-Daily pill improve life after kidney transplant?
Disease control CompletedThis study looked at kidney transplant patients taking either a once-daily or twice-daily version of the anti-rejection drug tacrolimus. The goal was to see if the once-daily pill led to fewer side effects, better medication adherence, and improved quality of life. 261 adults who…
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Kidney transplant study probes immune cells for better outcomes
Knowledge-focused CompletedThis study aims to learn more about the immune system in people who donate or receive a kidney transplant. Researchers will collect bone marrow and lymph node samples to study immune cells. The goal is to better understand how the body reacts to a transplant, which could help imp…
Matched conditions: KIDNEY TRANSPLANT RECIPIENTS
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 17, 2026 11:36 UTC